Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Rosai-Dorfman disease

A pathological experience from 2 tertiary care hospitals in Western Saudi Arabia

Jaudah A. Al-Maghrabi
Saudi Medical Journal April 2022, 43 (4) 341-347; DOI: https://doi.org/10.15537/smj.2022.43.4.20220028
Jaudah A. Al-Maghrabi
From the Department of Pathology, King Abdulaziz University, and from the Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia.
MD, FRCPC.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Dalia S,
    2. Sagatys E,
    3. Sokol L,
    4. Kubal T.
    Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control 2014; 21: 322–327.
    OpenUrlPubMed
  2. 2.↵
    1. Mantilla JG,
    2. Goldberg-Stein S,
    3. Wang Y.
    Extranodal Rosai-Dorfman disease: clinicopathologic series of 10 patients with radiologic correlation and review of the literature. Am J Clin Pathol 2016; 145: 211–221.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Bruce-Brand C,
    2. Schneider JW,
    3. Schubert P.
    Rosai-Dorfman disease: an overview. J Clin Pathol 2020; 73: 697–705.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Elshikh M,
    2. Schellingerhout D,
    3. Rayan J,
    4. Taher A,
    5. Elsayes AK,
    6. Mujtaba B, et al.
    Disease characteristics, radiologic patterns, comorbid diseases, and ethnic differences in 32 patients with Rosai-Dorfman disease. J Comput Assist Tomogr 2020; 44: 450–461.
    OpenUrl
  5. 5.↵
    1. Lu CI,
    2. Kuo TT,
    3. Wong WR,
    4. Hong HS.
    Clinical and histopathologic spectrum of cutaneous Rosai-Dorfman disease in Taiwan. J Am Acad Dermatol 2004; 51: 931–939.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Wang KH,
    2. Chen WY,
    3. Liu HN,
    4. Huang CC,
    5. Lee WR,
    6. Hu CH.
    Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in 6 patients. Br J Dermatol 2006; 154: 277–286.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Singh N,
    2. Sharma R,
    3. Verma UP,
    4. Singh SK,
    5. Dixit J,
    6. Balapure AK.
    Rosai-Dorfman disease in an Asian Indian woman with classic generalized lymphadenopathy and nasal obstruction: a case report. Ear Nose Throat J 2009; 88: E20–E23.
    OpenUrlPubMed
  8. 8.↵
    1. Al-Maghrabi B,
    2. Elnaggar T,
    3. Alamri O,
    4. Al-Maghrabi J.
    Orbital Rosai-Dorfman disease: a case report and literature review. J Microsc Ultrastruct 2019; 7: 50–52.
    OpenUrl
  9. 9.
    1. Al-Maghrabi H,
    2. Elmahrouk A,
    3. Feteih M,
    4. Jamjoom A,
    5. Al-Maghrabi J.
    Rosai-Dorfman disease with pulmonary involvement mimicking bronchogenic carcinoma. J Cardiothorac Surg 2020; 15: 37.
    OpenUrl
  10. 10.↵
    1. Baeesa SS,
    2. Mahboob H,
    3. Maghrabi Y,
    4. Binmahfoodh M,
    5. Almaghrabi J.
    Long-term outcome of spinal extranodal Rosai-Dorfman disease: a report of 2 cases and systematic review. World Neurosurg 2020; 144: 1–14.
    OpenUrlPubMed
  11. 11.↵
    1. Patwardhan PP,
    2. Goel NA.
    Isolated intraventricular Rosai-Dorfman disease. Asian J Neurosurg 2018; 13: 1285–1287.
    OpenUrl
  12. 12.↵
    1. Wei C,
    2. Zhou DB.
    Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of 3 cases. Hematology 2021; 26: 552–555.
    OpenUrl
  13. 13.↵
    1. Niu Y,
    2. Li Y,
    3. Wang J,
    4. Jin X,
    5. Yang D,
    6. Huo H, et al.
    Laryngeal Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy): a retrospective study of 5 cases. Biomed Res Int 2017; 2017: 8521818.
    OpenUrl
  14. 14.↵
    1. Demicco EG,
    2. Rosenberg AE,
    3. Björnsson J,
    4. Rybak LD,
    5. Unni KK,
    6. Nielsen GP.
    Primary Rosai-Dorfman disease of bone: a clinicopathologic study of 15 cases. Am J Surg Pathol 2010; 34: 1324–1333.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Brenn T,
    2. Calonje E,
    3. Granter SR,
    4. Leonard N,
    5. Grayson W,
    6. Fletcher CD, et al.
    Cutaneous Rosai-Dorfman disease is a distinct clinical entity. Am J Dermatopathol 2002; 24: 385–391.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Alharbi SS,
    2. Edward DP.
    Rosai-Dorfman disease: isolated epibulbar mass in patient with vernal keratoconjunctivitis. Saudi J Ophthalmol 2020; 34: 53–55.
    OpenUrl
  17. 17.
    1. Al-Jahdali HH,
    2. Al-Shirawi NN,
    3. Bamefleh HS,
    4. Yamani NM.
    Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman’s disease) as cause of isolated hilar lymphadenopathy and complete remission after high dose steroid. Saudi Med J 2008; 29: 763–765.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. AlKuwaity KW,
    2. Alosaimi MH,
    3. Alsahlawi KT,
    4. Alomair MA,
    5. Battyour MA,
    6. Alkuwaity DW, et al.
    Unusual presentation of Rosai-Dorfman disease: report of a rare case. Am J Case Rep 2019; 20: 91–96.
    OpenUrl
  19. 19.
    1. AlWadani S,
    2. Robinson S,
    3. Myers R,
    4. Akpek EK,
    5. Eberhart CG.
    No increase in IgG4-positive plasma cells in limbal Rosai-Dorfman disease. Cornea 2014; 33: 844–847.
    OpenUrl
  20. 20.↵
    1. Fathala A,
    2. Edathodu J,
    3. Bakshi N.
    FDG PET/CT in the evaluation of a rare case of multisystem involvement in newly diagnosed Rosai-Dorfman-Destombes disease. Saudi J Med Med Sci 2021; 9: 195–198.
    OpenUrl
  21. 21.
    1. Maklad AM,
    2. Bayoumi Y,
    3. Tunio M,
    4. Alshakweer W,
    5. Dahar MA,
    6. Akbar SA.
    Steroid-resistant extranodal Rosai-Dorfman disease of cheek mass and ptosis treated with radiation therapy. Case Rep Hematol 2013; 2013: 428297.
    OpenUrl
  22. 22.↵
    1. Al-Qahtani AS,
    2. Al-Shraim M.
    Rosai Dorfman disease of a 10 month Saudi infant: a case report. KKU Journal of Medical Sciences 2016; 1: 40–43.
    OpenUrl
  23. 23.↵
    1. Shalaby MAF,
    2. Al Humayed SM,
    3. Dewedar AM,
    4. El-Saeed TA.
    Asymmetric polyarthritis as an initial presentation of Rosai-Dorfman disease. Int J Rheum Dis 2008; 11: 311–314.
    OpenUrl
  24. 24.↵
    1. JI Wani IQ.
    Rosai Dorfman disease-case report of a patient with fatal outcome. JK Science 2011; 13: 160–161.
    OpenUrl
  25. 25.↵
    1. Kishore M,
    2. Gupta P,
    3. Ahuja A,
    4. Bhardwaj M.
    Cytodiagnosis of Rosai-Dorfman disease masquerading as lymphoma: a case report with brief review of literature. J Lab Physicians 2018; 10: 460–463.
    OpenUrl
  26. 26.↵
    1. Llamas-Velasco M,
    2. Cannata J,
    3. Dominguez I,
    4. García-Noblejas A,
    5. Aragües M,
    6. Fraga J, et al.
    Coexistence of Langerhans cell histiocytosis, Rosai-Dorfman disease and splenic lymphoma with fatal outcome after rapid development of histiocytic sarcoma of the liver. J Cutan Pathol 2012; 39: 1125–1130.
    OpenUrlPubMed
  27. 27.↵
    1. Garces S,
    2. Yin CC,
    3. Patel KP,
    4. Khoury JD,
    5. Manning JT Jr.,
    6. Li S, et al.
    Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Mod Pathol 2019; 32: 16–26.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Tiwari V,
    2. Pareek A,
    3. Ghori H,
    4. Ahirwar M.
    Rosai Dorfman disease and peripheral T-cell lymphoma: a rare co-occurrence. J Postgrad Med 2019; 65: 62–63.
    OpenUrlPubMed
  29. 29.↵
    1. Mehraein Y,
    2. Wagner M,
    3. Remberger K,
    4. Füzesi L,
    5. Middel P,
    6. Kaptur S, et al.
    Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations. J Clin Pathol 2006; 59: 1320–1326.
    OpenUrlAbstract/FREE Full Text
  30. 30.
    1. Tsang WY,
    2. Yip TT,
    3. Chan JK.
    The Rosai-Dorfman disease histiocytes are not infected by Epstein-Barr virus. Histopathology 1994; 25: 88–90.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Arakaki N,
    2. Gallo G,
    3. Majluf R,
    4. Diez B,
    5. Arias E,
    6. Riudavets MA, et al.
    Extranodal Rosai-Dorfman disease presenting as a solitary mass with human herpesvirus 6 detection in a pediatric patient. Pediatr Dev Pathol 2012; 15: 324–328.
    OpenUrlPubMed
  32. 32.↵
    1. Lardhi AA,
    2. Al-Mutairi AK,
    3. Al-Qahtani MH,
    4. Al-Mutairi AK.
    Rosai-Dorfman disease complicated by autoimmune hemolytic anemia in a child: a case report and review of the literature. Case Rep Oncol 2018; 11: 55–62.
    OpenUrl
  33. 33.↵
    1. Lopetegui-Lia N,
    2. Asad SD,
    3. Jafri SI,
    4. Harrison JS.
    Autoimmune diseases and Rosai-Dorfman disease coexist more commonly than expected: 2 case reports. Am J Case Rep 2019; 20: 770–772.
    OpenUrl
  34. 34.↵
    1. Shanmugam V,
    2. Margolskee E,
    3. Kluk M,
    4. Giorgadze T,
    5. Orazi A.
    Rosai-Dorfman disease harboring an activating KRAS K117N Missense mutation. Head Neck Pathol 2016; 10: 394–399.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Salama HA,
    2. Jazieh AR,
    3. Alhejazi AY,
    4. Absi A,
    5. Alshieban S,
    6. Alzahrani M, et al.
    Highlights of the management of adult histiocytic disorders: Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis. Clin Lymphoma Myeloma Leuk 2021; 21: e66–e75.
    OpenUrl
  36. 36.↵
    1. Garces S,
    2. Medeiros LJ,
    3. Patel KP,
    4. Li S,
    5. Pina-Oviedo S,
    6. Li J, et al.
    Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 2017; 30: 1367–1377.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Abla O,
    2. Jacobsen E,
    3. Picarsic J,
    4. Krenova Z,
    5. Jaffe R,
    6. Emile JF, et al.
    Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 2018; 131: 2877–2890.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Rane SR,
    2. Parkhi M,
    3. Vishwasrao S,
    4. Nakate L.
    Non-Hodgkin’s lymphoma with extensive emperipolesis mimicking Rosai-Dorfman disease: a rare case report. Indian J Pathol Microbiol 2019; 62: 319–322.
    OpenUrl
  39. 39.↵
    1. Goyal G,
    2. Ravindran A,
    3. Young JR,
    4. Shah MV,
    5. Bennani NN,
    6. Patnaik MM, et al.
    Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica 2020; 105: 348–357.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Bulyashki D,
    2. Brady Z,
    3. Arif S,
    4. Tsvetkov N,
    5. Radev RS.
    A fatal case of Rosai-Dorfman disease. Clin Case Rep 2017; 5: 1407–1408.
    OpenUrl
PreviousNext
Back to top

In this issue

Saudi Medical Journal: 43 (4)
Saudi Medical Journal
Vol. 43, Issue 4
1 Apr 2022
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rosai-Dorfman disease
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
Rosai-Dorfman disease
Jaudah A. Al-Maghrabi
Saudi Medical Journal Apr 2022, 43 (4) 341-347; DOI: 10.15537/smj.2022.43.4.20220028

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Rosai-Dorfman disease
Jaudah A. Al-Maghrabi
Saudi Medical Journal Apr 2022, 43 (4) 341-347; DOI: 10.15537/smj.2022.43.4.20220028
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prolonged flight exposure and its effects on sinonasal health among aircrew members
  • Identifying individuals at risk of post-stroke depression
  • Hematological parameters in recent and past dengue infections in Jazan Province, Saudi Arabia
Show more Original Article

Similar Articles

Keywords

  • Rosai-Dorfman disease
  • sinus histiocytosis
  • massive lymphadenopathy
  • Saudi Arabia

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire